Reza Falsafi Selected Research

Reza Falsafi Research Topics

Disease

13	Infections 11/2022 - 10/2008
7	Inflammation (Inflammations) 11/2022 - 02/2006
5	Sepsis (Septicemia) 01/2023 - 02/2006
2	COVID-19 01/2023 - 01/2023
2	Abscess 01/2022 - 12/2020
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 12/2012
1	Vasculitis (Vasculitides) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2020
1	Neoplasms (Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Bronchiectasis 01/2018
1	Lung Diseases (Lung Disease) 12/2012
1	Hemorrhagic Shock 11/2012
1	Bacterial Infections (Bacterial Infection) 08/2009
1	Chronic Granulomatous Disease 10/2008
1	Endotoxemia 02/2006

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 11/2022 - 12/2006
4	Antimicrobial Cationic PeptidesIBA 12/2020 - 02/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
2	EndotoxinsIBA 01/2022 - 10/2008
2	CytokinesIBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	innate defense regulating peptide 1018IBA 12/2020 - 01/2013
2	IDR 1002IBA 01/2019 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2017
1	Heme (Haem)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	InterferonsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	SphingomyelinsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	ivacaftor drug combination lumacaftorIBA 01/2021
1	ivacaftorIBA 01/2021
1	Interleukin-33IBA 12/2020
1	isopropyl methylphosphonic acidIBA 08/2020
1	Peptide Hydrolases (Proteases)FDA Link 08/2020
1	InterleukinsIBA 01/2020
1	Interleukin-27 (Interleukin 27)IBA 01/2020
1	pleurocidinIBA 01/2020
1	mastoparanIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	MucinsIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	AlginatesIBA 01/2017
1	p38 Mitogen-Activated Protein KinasesIBA 12/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2010
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2008
1	ChemokinesIBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006
1	Proteins (Proteins, Gene)FDA Link 02/2006
1	Toll-Like Receptor AgonistsIBA 02/2006
1	NF-kappa B (NF-kB)IBA 02/2006
1	CathelicidinsIBA 02/2006

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2012
1	Immunomodulation 01/2023
1	Aftercare (After-Treatment) 01/2019
1	Resuscitation 11/2012